Intrathecally administered dynorphin-(1–17) modulates morphine-induced antinociception differently in morphine-naive and morphine-tolerant rats

Garzon, 1982, Dynorphin-(1–13), a long-lasting inhibitor of opiate receptor binding in vitro, Life Sci., 31, 1789, 10.1016/0024-3205(82)90211-9

Goldstein, 1981, Porcine pituitary dynorphin: Complete amino acid sequence of the biologically active heptadecapeptide, 78, 7219

Herz, 1982, Differential distribution, release, and modulation of dynorphin and β-endorphin, 51

James, 1984, Opioid receptor selectivity of dynorphin gene products, J. Pharmacol. Exp. Ther., 228, 88

Lee, 1984, Possible regulatory function of dynorphin and its clinical implications, Trends Pharmacol. Sci., 108

Rezvani, 1984, Dynorphin-(1–13) restores the potency of morphine on the tolerant guinea pig ileum, European J. Pharmacol., 102, 475, 10.1016/0014-2999(84)90568-5

Rothman, 1982, Morphine allosterically modulates the binding of [3H]leucine enkephalin to a particulate fraction of rat brain, Mol. Pharmacol., 21, 538

Schulz, 1986, Opiates induce long-term increases in prodynorphin-derived peptide levels in the guinea-pig myenteric pluxus, Naunyn-Schmiedeb. Arch. Pharmacol., 333, 381, 10.1007/BF00500013

Smith, 1983, The multiple site β-endorphin receptor, Trends Pharmacol. Sci., 163

Tulunay, 1981, Possible regulatory role of dynorphin on morphine- and β-endorphin-induced analgesia, J. Pharmacol. Exp. Ther., 219, 296